Detalhe da pesquisa
1.
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Curr Oncol
; 30(7): 6289-6315, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504325
2.
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Curr Oncol
; 30(7): 6473-6496, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504336
3.
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
Curr Oncol
; 28(6): 4552-4576, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34898564
4.
A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC.
Cancer Chemother Pharmacol
; 83(3): 411-417, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535909
5.
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy.
Lung Cancer
; 120: 142-148, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748010